Health worker Carla Diaz holds a vial of the Moderna vaccine against the coronavirus disease (COVID-19) at a vaccination center in Buenos Aires, Argentina August 9, 2021. REUTERS/Agustin Marcarian
Moderna Inc (MRNA.O) is planning to double the size of an ongoing trial testing its COVID-19 vaccines in children aged six months to less than 12 years.
According to updated details on clinical trial record site clinicaltrials.gov, the study will now enroll an estimated 13,275 participants, nearly double the earlier target of 6,975 participants.
In July, Moderna said it was in discussions with the U.S. Food & Drug Administration to expand the study with an objective to enroll a larger safety database, which increases the likelihood of detecting rarer events.
The company's vaccine, which received its emergency authorization for people aged 18 and older in the United States in December, is currently under an FDA review for use in adolescents.
Reporting by Mrinalika Roy in Bengaluru; Editing by Maju Samuel
Afghan Women Speaks on Unyielding Hope of Restoring Their Homeland
QF to Host Education-Focused Virtual Events at United Nations General Assembly and Global Goals Week
Outsourcing Physical Therapists for Enlisted Jobs in Qatar
Qatar SC wins HH the Amir’s Table Tennis Cup 2020-2021 season
Pfizer: Know all about the Covid-19 vaccine and its usage in Qatar
FIFA’22 over Covid-19: Qatar limbers up for the World Cup amidst a worldwide pandemic
Top 5 Art Galleries You Must Explore in Qatar
The Expert Outsourcing Service in Qatar That Guides You in Employing a Qualified Graphic Designer